< Back to previous page
Researcher
Arnold Vulto
- Disciplines:Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences
Affiliations
- Clinical Pharmacology and Pharmacotherapy (Division)
Member
From1 Oct 2017 → Today
Projects
1 - 1 of 1
- A Belgian policy framework for best-value biological medicinesFrom3 Sep 2019 → 18 Sep 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 84
- A Belgian policy framework for best-value biological medicines(2023)
Authors: Yannick Vandenplas, Isabelle Huys, Steven Simoens, Arnold Vulto
- The impact of policy interventions to promote the uptake of biosimilar medicines in Belgium: a nationwide interrupted time series analysis(2023)
Authors: Yannick Vandenplas, Steven Simoens, Arnold Vulto, Isabelle Huys
- Biosimilar competition in European markets of TNF-alpha inhibitors: a comparative analysis of pricing, market share and utilization trends(2023)
Authors: Elif Car, Arnold Vulto, Isabelle Huys, Steven Simoens
- Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi study(2023)
Authors: Patrick Verschueren, Arnold Vulto
- An exploration of biosimilar TNF-alpha inhibitors uptake determinants in hospital environments in Italy, Portugal, and Spain(2023)
Authors: Arnold Vulto, Isabelle Huys, Steven Simoens
- Evaluating the benefits of TNF-alfa inhibitor biosimilar competition on off-patent and on-patent drug markets: A Southern European analysis(2022)
Authors: Teresa Barcina Lacosta, Arnold Vulto, Isabelle Huys, Steven Simoens
- IGF2-tagging of GAA promotes full correction of murine Pompe disease at a clinically relevant dosage of lentiviral gene therapy(2022)
Authors: Arnold Vulto
Pages: 109 - 130 - How to select a best-value biological medicine? A practical model to support hospital pharmacists(2022)
Authors: Liese Barbier, Yannick Vandenplas, Isabelle Huys, Arnold Vulto
Pages: 2001 - 2011 - Determinants of prescribing decisions for off-patent biological medicines in Belgium: a qualitative study(2022)
Authors: Yannick Vandenplas, Steven Simoens, Arnold Vulto, Isabelle Huys
- Biosimilar Use and Switching in Belgium: Avenues for Integrated Policymaking(2022)
Authors: Liese Barbier, Steven Simoens, Paul Declerck, Arnold Vulto, Isabelle Huys